MEDIFAST INC Valuation

MED Stock  USD 11.34  0.04  0.35%   
At this time, the firm appears to be undervalued. MEDIFAST INC secures a last-minute Real Value of $13.17 per share. The latest price of the firm is $11.34. Our model forecasts the value of MEDIFAST INC from examining the firm fundamentals such as return on equity of 0.0012, and Profit Margin of 0.0006 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting MEDIFAST INC's valuation include:
Price Book
0.5815
Enterprise Value
-36.4 M
Enterprise Value Ebitda
0.0453
Price Sales
0.289
Trailing PE
565
Undervalued
Today
11.34
Please note that MEDIFAST INC's price fluctuation is not too volatile at this time. Calculation of the real value of MEDIFAST INC is based on 3 months time horizon. Increasing MEDIFAST INC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MEDIFAST stock is determined by what a typical buyer is willing to pay for full or partial control of MEDIFAST INC. Since MEDIFAST INC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MEDIFAST Stock. However, MEDIFAST INC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  11.34 Real  13.17 Target  15.0 Hype  11.3
The real value of MEDIFAST Stock, also known as its intrinsic value, is the underlying worth of MEDIFAST INC Company, which is reflected in its stock price. It is based on MEDIFAST INC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MEDIFAST INC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
13.17
Real Value
15.59
Upside
Estimating the potential upside or downside of MEDIFAST INC helps investors to forecast how MEDIFAST stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MEDIFAST INC more accurately as focusing exclusively on MEDIFAST INC's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-0.4-0.4-0.4
Details
Hype
Prediction
LowEstimatedHigh
8.8811.3013.72
Details
1 Analysts
Consensus
LowTarget PriceHigh
13.6515.0016.65
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use MEDIFAST INC's intrinsic value based on its ongoing forecasts of MEDIFAST INC's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against MEDIFAST INC's closest peers. If more than one evaluation category is relevant for MEDIFAST INC we suggest using both methods to arrive at a better estimate.

MEDIFAST INC Cash

109.8 Million

MEDIFAST Revenue by Product

MEDIFAST INC Total Value Analysis

MEDIFAST INC is now forecasted to have company total value of (36.39 M) with market capitalization of 124.2 M, debt of 16.12 M, and cash on hands of 90.93 M. The negative valuation of MEDIFAST INC may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the MEDIFAST INC fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(36.39 M)
124.2 M
16.12 M
90.93 M

MEDIFAST INC Investor Information

About 86.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEDIFAST INC has Price/Earnings To Growth (PEG) ratio of 1.95. The entity last dividend was issued on the 18th of September 2023. The firm had 1:20 split on the February 14, 2011. Based on the measurements of operating efficiency obtained from MEDIFAST INC's historical financial statements, MEDIFAST INC is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Profit Margin0.00410.0043
Notably Down
Pretty Stable
Operating Income3.1 M3.3 M
Notably Down
Slightly volatile

MEDIFAST INC Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MEDIFAST INC has an asset utilization ratio of 211.98 percent. This indicates that the Company is making $2.12 for each dollar of assets. An increasing asset utilization means that MEDIFAST INC is more efficient with each dollar of assets it utilizes for everyday operations.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

MEDIFAST INC Profitability Analysis

Based on the measurements of profitability obtained from MEDIFAST INC's financial statements, MEDIFAST INC may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess MEDIFAST INC's ability to earn profits and add value for shareholders.
 
Net Income  
First Reported
1996-09-30
Previous Quarter
2.5 M
Current Value
-2.3 M
Quarterly Volatility
11.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
As of February 10, 2026, Gross Profit is expected to decline to about 270.6 M. In addition to that, Pretax Profit Margin is expected to decline to 0.01
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.540.66
Significantly Down
Very volatile
Net Profit Margin0.0030.0031
Notably Down
Very volatile
Operating Profit Margin0.00410.0043
Notably Down
Pretty Stable
Pretax Profit Margin0.00540.0057
Notably Down
Pretty Stable
Return On Assets0.00630.0066
Notably Down
Pretty Stable
Return On Equity0.01090.0114
Sufficiently Down
Pretty Stable
For MEDIFAST INC profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MEDIFAST INC to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MEDIFAST INC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MEDIFAST INC's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MEDIFAST INC over time as well as its relative position and ranking within its peers.

MEDIFAST INC Earnings per Share Projection vs Actual

The next projected EPS of MEDIFAST INC is estimated to be -0.4025 with future projections ranging from a low of -0.4025 to a high of -0.4025. MEDIFAST INC's most recent 12-month trailing earnings per share (EPS TTM) is at 0.02. Please be aware that the consensus of earnings estimates for MEDIFAST INC is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
MEDIFAST INC is projected to generate -0.4025 in earnings per share on the 31st of December 2026. MEDIFAST INC earnings estimates show analyst consensus about projected MEDIFAST INC EPS (Earning Per Share). It derives the highest and the lowest estimates based on MEDIFAST INC's historical volatility. Many public companies, such as MEDIFAST INC, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

MEDIFAST INC Earnings Estimation Breakdown

The calculation of MEDIFAST INC's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of MEDIFAST INC is estimated to be -0.4025 with the future projection ranging from a low of -0.4025 to a high of -0.4025. Please be aware that this consensus of annual earnings estimates for MEDIFAST INC is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.0
-0.4
Lowest
Expected EPS
-0.4025
-0.4
Highest

MEDIFAST INC Earnings Projection Consensus

Suppose the current estimates of MEDIFAST INC's value are higher than the current market price of the MEDIFAST INC stock. In this case, investors may conclude that MEDIFAST INC is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and MEDIFAST INC's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2026Current EPS (TTM)
132.69%
0.0
-0.4025
0.02

MEDIFAST INC Ownership Allocation

The market capitalization of MEDIFAST INC is $124.2 Million. The majority of MEDIFAST INC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MEDIFAST INC to benefit from reduced commissions. Thereupon, institutional holders are subject to a different set of regulations than regular investors in MEDIFAST INC. Please pay attention to any change in the institutional holdings of MEDIFAST INC as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.

MEDIFAST INC Profitability Analysis

The company reported the last year's revenue of 602.46 M. Total Income to common stockholders was 2.09 M with profit before taxes, overhead, and interest of 311.27 M.

MEDIFAST INC Past Distributions to stockholders

Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MEDIFAST INC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MEDIFAST INC and how it compares across the competition.

About MEDIFAST INC Valuation

The stock valuation mechanism determines MEDIFAST INC's current worth on a weekly basis. Our valuation model uses a comparative analysis of MEDIFAST INC. We calculate exposure to MEDIFAST INC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MEDIFAST INC's related companies.
Last ReportedProjected for Next Year
Gross Profit511.3 M270.6 M
Pretax Profit Margin 0.01  0.01 
Gross Profit Margin 0.66  0.54 
MEDIFAST INC's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether MEDIFAST INC's value is low or high relative to the company's performance and growth projections. Determining the market value of MEDIFAST INC can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of MEDIFAST INC represents a small ownership stake in the entity. As a stockholder of MEDIFAST, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

MEDIFAST INC Dividends Analysis For Valuation

Please note that MEDIFAST INC has scaled down on payment of dividends at this time. At present, MEDIFAST INC's Earnings Yield is projected to slightly decrease based on the last few years of reporting.
There are various types of dividends MEDIFAST INC can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of MEDIFAST shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from MEDIFAST INC directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When MEDIFAST pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of MEDIFAST INC by the value of the dividends paid out.

MEDIFAST INC Growth Indicators

Investing in growth stocks can be very risky. If the company such as MEDIFAST INC does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding11 M
Quarterly Earnings Growth Y O Y-0.872

MEDIFAST INC Current Valuation Indicators

Valuation refers to the process of determining the present value of MEDIFAST INC and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value MEDIFAST we look at many different elements of the entity such as MEDIFAST's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as MEDIFAST INC, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use MEDIFAST INC's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes MEDIFAST INC's worth.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio